Current Perspectives on the Therapeutic Utility of VR1 Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|24|3185-3202

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.24, 2004-12, pp. : 3185-3202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 482-503

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 344-357

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Clinical Utility of aVR—The Neglected Electrocardiographic Lead

By Kireyev Dmitriy   Arkhipov Mikhail V.   Zador Stephen T.   Paris Joseph A.   Boden William E.  

Annals of Noninvasive Electrocardiology, Vol. 15, Iss. 2, 2010-04 ,pp. : 175-180

Blackwell Publishing

Access to resources Recommend Favorite